visa appear and gilead reporting after the bell we havecoverage. the call but kate roger on visa. >> the call stig going on. but visa without with beats on the top on a bottom lines payment volume up 9% year over year processes transactions nnlzed by 11% to $36.4 billion pfeffer client incentives at $1.7 billion ceo laid out the company priorities in order to be a leader lead ner the space on the call take a listen. >> drive populars for trshl clients. expand access with new players seller sin tech, increased customer engagement by enabling a variety of platforms and simplifies the payment experience extending value end capabilities across the ecosystem and enabling new money movement with our network of networks. >> the company also announcing a quarterly dividend increase of 20% to 30 cents per share. the stock up over 30% year to date had been down in the past three months np. initially got a pop as the earnings report came occupy now it's up just slightly again. anything we hear from the call we'll bring to you over to you. >> kate rogers at he

teenagers, one growing up in gilead and one growingng up over the boborder in canada.erersonally, it wathee one i i most enjoyeded leading m -- reading from the shortlist. . was a tiny bit disappointed i don't want to give too much away, but i will say some situations did not quite deal rerealistic within gilead. but i think atwood i is injectig hope. annette: have you been spoiled by the tv series? >> it is so gruesome that i prefer reading it. tell us a little bit more about this particular one. >> it is the longest shortlist in recent history. quite a challenge to get through . it is also praised for its diversity. the most diverse in the 50 year history. four women among six finalists. no white men were among the authors. were the british author and activist. also salman rushdie. and a nigerian author. criticism, this for putting star names on ththere a and not lettg enouough new talent onon the shorortlist.t. the prize isng often criticized for his accessibility and maybe not being in touch with what readers are more broadly connecting with. the best on the long l

for gilead it's all about its different drug franchises.nt basically in line 4.2 billion for the quarter versus consensu of 4.9 he hepatitis drugs came in light. for full year guidance company raised the bottom end of the range they are looking for up now to 21.8 to $22 billion you are seeing gilead off by 1.5% perhaps on the miss on the hepatitis revenues hiv drugs overall did meet consensus. >>> thanks very much for that broad final comment, steph on earning. what are you taking way from this that value growth >> value growth debate but also stock picker market. really truly you got to get them right other wise you'll get your head handed to you lam was fabulous, twitter was horrible let's see if the reactions are what they are. if you get rewarded. >> 77% move in opposite directions stephanie and tim thank you for joining us great to see you both. >>> up next, we'll have much more on amazon's earnings. keep it right here "closing bell" is back in 90 seconds. this piece is talking to me. yeah? so what do you see? i see an unbelievable opp

what they found is that gilead is going -- after that hearing gilead announced or right before or after that hearing come right before -- i don't know. they knew this was coming, and the announced that they are going to make prep generic a year earlier than they were anticipating, which is next year. after our hearing. so after hearing the announced that they're going to send prep generic. we have it went on prep but they're still so much to go from research to public policy that is backed by public health research, because hiv is also like us it is a social disease. when we talk with hiv we need to talk about homelessness crisis. when we talk with hiv we need to talk to drug opioid addiction, we need to talk about the social stigmas that are put against the lgbtq community and also anyone that contracts hiv. so we have a lot of work to do. this president mentioned goals around hiv. you know, so long as his goals are constructed, like i will pitch in. i'm going to not work with them just because of his name. i will double check his work. [laughing] but i'm not strictly partisan in that

i felt it was time to revisit gilead and see how it all fell apart.d to win the love of his life. what inspired the story? so i went to school in cyprus in 2009 and i encountered a tiger came from nigeria and he got depressed and went up and died from there, so in the aftermath of that tragic event, i rememberwhat there, so in the aftermath of that tragic event, i remember what he told me that he did this because he was in love with a woman in nigeria and he sold everything he had so i wanted to retrace this journey and that's what inspired the novel. he traced his journey and that's what inspired the novel. he traced hisjourney and give him a voice. margaret i wonder if you can tell me how much you think you have changed as a writer since you wrote the handmade scale? changed as a writer since you wrote the handmade scale ?|j changed as a writer since you wrote the handmade scale? i got a lot older. apart from that. i don't know ifa older. apart from that. i don't know if a hard question, i can't actually remember what i was like then,. has it become

it is called gilead. gilead was charging month in the united states for prep, the medication that helps prevent the transmission of hiv-aids. if you are charging someone , or even in a city $2000 a , month to keep someone from spreading a disease, if they cannot afford that, where does that leave the rest of us? we brought them in and here's what we found. they were charging over $2000 a month for prep. who paid to develop it? we found out the public did. the cdc or nih funded critical research that established and identified the beginnings of what became prep. gilead simply picked it up and started selling it for $2000 a month. what we paid for. this is not just happen with prep. it happens with a lot of other medications. not only did we find that the company did this, that the public is actually entitled if not a royalty than the patent, but we brought them in and i asked him, this is funny, you are charging $2000 in the united states. in australia, you are charging six dollars to eight dollars. we hav

other form of life you get to see it through a young woman who's grown up across the border from gileadple move >> seth: mm-hm >> and they have done that many times in history so they're doing it again. and then we see it through the point of view of somebody who's been a foundational person from the beginning of gilead, namely aunt lydia of the aunts. whom we see in "handmaid's tale" only from the outside, only through the eyes of the narrator we know nothing about how she got into that position so we find her writing her own narrative -- her own secret narrative. >> seth: i have one last thing to ask you i hope this is okay. i have heard that outside of being an accomplished author, you also read palms. is this accurate >> you up for this [ laughter ] [ cheers and applause >> seth: i'm up for it is there a preference? do you -- do you -- does it matter which palm? >> i'm not doing the mumu stuff. i'm not reading your aura. >> seth: okay. >> this is straight renaissance palmistry which goes along with astrology. >> seth: okay. >> are you right or left handed? >> seth: i'm right handed.

got to be really careful you can't own one of these stocks unless you really know it well gilead, noe. down 20% of course, it's a great drug i would stick with bio tech. i'd even buy more because that is a safer place to me from a regulatory standpoint. >> okay. world wrestling entertainment shares have been slammed over the past six months falling more than 20% options traders, though, are betting on a jump off the top rope john -- >> i love these puns. >> we should've brought him in boom. >> you're right, scott wwe, this one is poised to do very well. woo. that's a little rick flare for you. they're buying those aggressively today, scott. thousands and thousands of these calls have gone off. i bought those it's about a three-month trade into the future. so i'll be in these probably two to three months. second one real quick. ashr this one is, of course, a china play big upside call buying at the 28.50 strike i like that activity very much lastly, quick update on amit therapeutics this one, up 4% today. we talked about it yesterday still has even more unusual activity today. 'll key

. >> so -- >> seth: yeah, there's some -- there's some added -- some sass that you don't see in gilead seth: do you -- how did this come about how did this show come about >> this -- i had been dying to do a comedy. jason winer who -- >> seth: i went to college with. an old college buddy of mine, jason winer. >> oh, really? oh, wow. well, he is wonderful. he directed "modern family" pilot. i love "modern family. i really wanted to meet with him. and lesley wake webster, her grandfather went through a very difficult time at the end of his life, was a big choir director and end up in this church in kentucky and it's got a real kind of "parks and rec" feel with this added musical element. it's a lot of fun. >> seth: and - >> and i play a broken man >> seth: you play a broken man >> yeah, that's my wheelhouse. >> seth: will we see you sing? is that going to happen? >> you will. >> seth: okay. >> you will. [ laughter ] you will at some point >> seth: it was just an anniversary as mentioned on the emmys when you - >> yes >> seth: and jimmy smits, 20 years-- >> 20 years. >> seth: on sunday of

little bit of the smoke now so it looks like it is still burning in fact over there we come over here gilead you consume and beyond those trees you might be able to see some of the red lights off in the distance right there be on the trees elise i can see it so looks like right there the first responders are on that ridge line and obviously still battling the fire this is about 3 hours into it a little hard from this vantage point to see, but i did see a whole bunch of red lights beyond the ridge line you can see the cars here as well as people. leaving their homes doing the best that they possibly can you talked about it. the fire is only 50% contained at this point still burning i would imagine out of control. fortunately saint mary's and st. mary's is near this location. it does not me and does not seem that that college at this particular time has been threatened. look at that rob and more and more cars are coming through here, we'll get a little bit closer to the ridgeline give you a great vantage point of the fire. and our next report back to well just very quick question for you as we

and if gilead fails to honor their commitment to the taxpayer, to our fellow americans we will take over that patent and we will make sure that prep is distributed to every person in america who needs that. and the discrimination against those who have hiv in america today. >> congressman, if you will, let me follow up on that. >> sure. >> in dozens of states in this country a person can be prosecuted for not revealing their hiv status. a person can face up to 15 years in prison for not disclosing their status. even if it means it's undetectable. should these laws be overturned? >> i think they should. i think the goal has to be equal treatment, which we've been talking about here today, nondiscrimination in america and it also has to be on the public health needs of our fellow americans. instead of being focus on pen penalizing or punishing or incarcerating people with hiv, what if we focused on stopping the spread of hiv in the manner i just described, making sure prep is affordable and available and accessible to every american who needs to use it with more than 1.3 million at risk to

. >> maybe give a little love to gilead sciences.lts and their latest earnings report. this is a big biotech stock. they have a rock solid balance sheet. there's been a shuffle in the executive suite that suggests they may be doing some deals going forward, and you get paid about 4% on the dividend while you wait. >> and if they get their next big drug discovery, then it's a real winner. lauren, al, ben, thank you very much. all great ideas. to read more, check out this edition at barron's.com. that's all for us tonight. see you next week on "barron's roundtable." mug. ♪ n underwater strange inheritance. >> we've had this in the family since 1899. >> their world's an oyster. >> do you want to try and shuck >> i would. it's all about the shuck. >> but their biz is belly-up. >> they pretty much said this oyster-planting business is over. >> they want to revive it. >> a couple drinks make anything sound good. >> so, will they sink... >> we looked at our debt for the first time, like, "whoa. it's, like, $350,000". >> ...or float? >> okay

a monthly supply of truvad accosts less than $6 to make, however its manufacturers, gilead charges moren $1,600. this severely limits access to preventive care. what actions would you take as president to address this cost barrier? >> so -- thank you. that was a great question. that is a really great question. and i live in a low-income black and brown community and in fact, when it comes to hiv and aids we see often the communities are most seeing the expansion, the ones that are least able to access a lot of the drugs that can do preventative prep. for me it's unacceptable that companies would profit in this way to prevent life-saving drugs. we will lower prescription drug costs right away by using medicaid and medicare to negotiate down prices and taking patents away from companies that unjustly raise prices and creating a law in this country that you cannot raise the price higher in this country than you're selling in others. prep is so important in this country right now and i'll make sure like gavin newsom did to have it be over the counter without a prescription. that's a great s

. >> maybe give a little love to gilead sciences.nue results and their latest earnings report. this is a big biotech stock. they have a rock solid balance sheet. there's been a shuffle in the executive suite that suggests they may be doing some deals going forward, and you get paid about 4% on the dividend while you wait. >> and if they get their next big drug discovery, then it's a real winner. lauren, al, ben, thank you very much. all great ideas. to read more, check out this edition at barron's.com. that's all for us tonight. see you next week on "barron's roundtable." mug. - [announcer] the following is a paid advertisement for the bissell crosswave cordless max, sponsored by bissell. - what is that? - what does it do? - [narrator] it vacuums. - i thought so. - [narrator] and washes. - and washes? - [narrator] at the same time. - [both] at the same time? - [narrator] uh-huh. - [woman] can it clean this? - [narrator] yes. - [woman] how about this? - [narrator] yep. - [woman] what about this? - [narrator] sure. - even this? - [narr

i do think she has done interesting things with the gilead world that she created, as she has hintedhat this whole world that isa they are that this whole world that is a terrible dystopia, elements of hope, elements of possibility, rebellion with from within. that is interesting. it is a sequel, does that mean that cannot when? they are up that mean that cannot when? they are up against different books, so... she didn't win for the had made's tale, she has been shortlisted six times. she won in 2000. from the old is right on the shortlist about margaret atwood is nearly 80, to the youngest, chigozie 0bioma, nigerian author, 32, this is a second novel. an 0rchestra author, 32, this is a second novel. an orchestra of minorities. his first was shortlisted as well. this is told from the point of view of a spiritual guardian of the main character. what did jamaica that narrative framework? it is an incredible achievement as a book, i found that the tradition from nigerian culture, the idea of this guardian spirit, a lot of the time it detaches you quite significantly from the main charac

gilead simply printed up and started selling it for $2000 a month. this is not just happen with prep. it happens with a lot of other medications. not only did we find that the company did this, that the public is actually entitled if not a royalty than the patent, we brought them in and i asked him, this is funny, you are charging $2000 in the united states. charging eightur dollars. we have multiple tools as legislators. the bully pulpit is one of them. they do not like to be exposed. sometimes we pass laws to force things to happen. bullymes we can use the pulpit to expose what is happening to the public. gilead, after that hearing, they that they are going to make prep should there are year earlier than they were anticipating. prep.but win on there is still so much to go. hiv is a social disease. we also need to talk about her homelessness crisis. we need to talk about opioid addiction. the social stigmas that are put against the lgbt community. anyone who contracts hiv. we have a lot of work to do. this president mentioned goals around hiv. orlon

you might have heard about this brexit thing gilead, stocks are down the excitement over that run up to be muted. volume appears to be eneemic the size of trades has come down some worry that another december-like melt down could happen again or worse. we spoke with president of modern ir and i asked why all of this matters >> do you look at the data, the liquidity measures have gone down, down we tli liquidity is the amount of something you can buy brokers are required to post a minimum 100 shares to buy or sell if you look at the s&p 500, this was the point i raised in the market watch piece that the s&p 500 trades at 135 share increments if you look underneath that, almost half of all trades are less than 100 shares you look at the size of black rock and state street. >> you just talked about how the actual sizes of the trades are getting smaller as well. is that in some way a taste of things to come is. >> yes if you look at the data in 2015, the same figure shifted to etf, about $360 billion there was a net zero change. how does the market go down 20%? the answer has to be a sup

so they found is that gilead is going to after that hearing, gilead announced or read before or after, we were making the hearing, they knew this was coming and they announced that they are going to make prep generic a year earlier than they were anticipating which is next year. after our hearing. so after our hearing, theyng announced that they going to do this week have a win on prep. but there's still so much to go. from research to public policy that is backed by public health research because hiv is also, is the social disease. were talking about her homelessness crisis. and drug opioid addiction and we'll talk about hiv we need to talk about all these other things social stigmas against the lgbt communities and also anyone that contracts hiv. so we have a lot of work to do. this president mentioned goals on hiv, so long as his goals are constructive, but jen. an ongoing did not work with them just because of his name. i will double check his work. [laughter] but i'm not strictly partisan in that way. but i do think that we hiv is the disease that can be ended in the generation.

i am feeling the same celebratory joy as when a handmaid is able to escape gilead and live in freedomu're talking about "the handmaid's tale." i've never seen the show. >> you'll like it. >> it's a good one. by the way, you don't have to watch the show because you're living it. go ahead. >> does this really bring you joy? >> yes. it brings me joy. so i'm a little torn on it. i'm torn on it as far as what it means for balance to fox and what it means for journalism. >> that viewers will never hear facts -- rarely. >> it is so important to have shep smith's voice at fox news. i'm happy for shep smith. he's also a human being. he is a very decent human being, and i want him to be happy. so, yeah, i did feel like, oh, my god, he's finally free not to be constrained by a network where there is such editorial control and where he is, you know, such the man out where the president is constantly tweeting against him. he's finally free to speak the truth without any reservation, and i want him to be happy. >> yeah. speaking of that, the president -- president trump assumes that he left because

set 15 years later, it follows three women in the totalitarian state of gilead.spirit from ego culture. bernadine ever bestow‘s girl woman other, featuring women mostly black and british, with interconnected stories. it is told in free verse. in ten minutes 38 seconds in the strange world, relief fact chronicles the life and death of a woman who becomes a six worker in istanbul. dead in a dustbin while her brain remains active, we learn her brain remains active, we learn her story. lucy ellman has written ducks, newburyport, which takes us inside the koteka mind of a housewife from ohio trying to deal with modern life. salman rushdie's key short, is a retelling of cerva ntes's key short, is a retelling of cervantes‘s donkey ot. it is but a travelling salesman pursuing an unobtainable woman across america. i am delighted to say we are joined by two of those authors now, salman rushdie and lhr fight. your book is about modern america and yet it is davey imagining of a 17th—century novel. how did that inspire your book? ulysses was inspired by a big written thousand

what can i help you with >> caller: gilead, what do you think?> i'd rather go to chinos than gill & gee know's is better nelson in new jersey >> caller: big tiger booyah from princeton, university for you jim. i'm here with my friend brad we've got a question about a marijuana stock, hexo corp. >> that is speculative the canopy growth because it's almost like half cash. i'm putting the hex on hexo let's go to martin in new york >> caller: hi jim, booyah. >> oh, man, really >> high speed chip interface i'm going to tell you to buy nvidia on the way down rather than now when i think it's just a better stock and it's worth it to take a shot it's not a shot. i would invest in nvidia john in washington >> caller: yes, sir, tell me wonderful things about kroger. >> i'd rather tell you wonderful things about costco, which is crushing kroger. ladies and gentlemen, lightning round. >> lightning round is sponsored by td ameritrade take control of your financial future, cramer's exclusive ceo interviews, full episodes, analysis, even your own sound board. p

i was shocked at their investments, for instance, of gilead science, eastman chemical, digital realtyhe cash flow, all the things that go into making an investment? lauren: each presentation, there was 11 for undergrad, 11 for grad, takes about 48 hours of research. neil: what kind of portfolio are they looking at? is the class united on this? lauren: they have to vote. each of the students, well, because they are part of a group and that group has to make their presentation to the class, then the class votes on the internet. but instantaneously, okay, we vote that you can put 20% of this money into that stock. whatever the class says is what they do. democracy. neil: you sound like you have your doubts. >> um-hum. neil: you do. lauren: why? you want to give your kids $10 million to invest in the stock market? >> excuse me? neil: he wants them to be self-sufficient. more after this. including the grilling by boeing's ceo on capitol hill today. it did not go well. that's an understatement. after this. what a time to be alive. the world is customized to you. built for you. so why isn't

soaring on its news it is seeking fda approval for its alzheimer's drug along with biogen, celgene, gileadarticipating >> shares of biogen are up megterrell has been following the story. a question to you, many of us remember when we initially got the results from this same trial back in march andthe stock fel dramatically this morning we get the news that they're going to submit perhaps as an early 2020 a new drug application based on additional data on different dosing explain to me what changed as to why something that seemed to be a fail is now potentially going to be seen as a suck es? >> it is a fascinating story, david. this was a drug that everybody thought was completely dead. we can keep scrolling up the news in march wiped more than $15 billion from the market value and quashed the hopes of millions with alzheimer's disease and targeting the amyloid buildup in the brain biogen says a further analysis of more data that became available after its initial analysis showed the drug called aducanumab appears to work slowing in declines in memory, language and ability to think clearly